Dartmouth Logo

Dartmouth Logo

Tuesday, July 30, 2013

Systemic Amyloidosis: Basic, Translational, and Clinical Research (R01)

Funding Opportunity Announcement (FOA) Number
Companion Funding Opportunity
Number of Applications
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.847, 93.399; 93.396; 93.395; 93.394; 93.393, 93.866  
Funding Opportunity Purpose
The purpose of this Funding Opportunity Announcement (FOA) is to invite qualified basic science and clinical investigators to submit applications for research projects designed to advance the understanding of pathogenic mechanisms underlying systemic amyloidosis, to develop improved techniques (in particular those that are non-invasive) for the clinical detection and diagnosis of systemic amyloid diseases, to develop novel cellular and in vivo models with which to identify candidate therapeutic agents, and to evaluate the clinical efficacy of novel therapies designed to prevent, arrest, and (when possible) reverse the morbid and lethal progression of these diseases.   
Key Dates
Posted Date
July 26, 2013
Open Date (Earliest Submission Date)
September 5, 2013
Letter of Intent Due Date(s)
Not Applicable
Application Due Date(s)
Standard dates apply, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

No comments:

Post a Comment